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Abstract
Introduction and objectives. Inflammatory bowel disease (IBD) is long life disease that results from an interaction between 
a polygenetic predisposition and environmental factors, including smoking. The aim of this study was to evaluate beliefs 
about and awareness of smoking among adolescents with IBD compared to healthy controls.  
Materials and method. Patients with IBD, Crohn’s disease (CD) and ulcerative colitis (UC), and healthy controls were asked 
to complete a questionnaire on demographic data and smoking status. The questionnaire also included data on beliefs 
and awareness of smoking-related health effects, including effects on IBD.  
Results. A total of 139 IBD patients and 108 controls were enrolled in the study. Of the IBD patients, 17/139 (12.2%) were 
smokers compared to 18/108 (16.7%) of controls (p=0.3). Patients with IBD were nine times more likely to be everyday smokers 
than occasional smokers (OR=9.2, 95% CI: 1.9- 45.1, p=0.004). No difference was found between patients with CD and UC 
in their answers to the question of whether “smoking increases the risk for surgery in your type of IBD” (17/28 (60.7%) vs. 
10/29 (34.5%), respectively (p=0.047). More patients with CD than UC were aware of the risks of smoking on their disease: 
extra-intestinal manifestations and disease exacerbation, OR=11.3 (95% CI: 4.1 – 30.9; p=0.000) and OR=19.3 (95% CI: 6.7 – 
55.1; p=0.000), respectively.  
Conclusions. The data obtained demonstrated that adolescents with CD are much more aware of the role of smoking on CD 
than are their peers with UC; however, this awareness is still unsatisfactory. Therefore, there is an unmet need to implement 
better anti-smoking strategies for this group of patients.
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INTRODUCTION
The etiology of inflammatory bowel disease (IBD), including 
ulcerative colitis (UC) and Crohn’s disease (CD), has not been 
fully described. However, some of the genetic, immunologic 
and environmental factors that contribute to the development 
of IBD are well established [1]. Among environmental factors, 
the role of smoking is one of the most curious. It has already 
been proven that tobacco smoking has a dichotomous effect 
on the course of IBD: it is protective for patients with UC 
and negative for patients with CD [1, 2, 3]. Cigarette smoking 
significantly reduces risk of UC occurrence, compared to non-
smokers (OR 0.58; 0.45–0.75) [4], diminishes hospitalization, 
relapse rates, and needs for corticosteroids and colectomy [5]. 
As for CD, smoking significantly increases the risk of illness 
prevalence, worsens the course of disease and quality of life. 
Smokers with CD are more likely to present with extra-intestinal 
symptoms, to have disease exacerbation and more frequently 
require hospitalization. They are less responsive to treatment 
and more prone to developing complications. They also are at 
higher risk of surgery and of postoperative relapse [6, 7].
Importantly, individuals who decide to give up smoking 
have a similar prognosis as CD patients who never smoked 
[5]. On the other hand, ex-smokers have increased risk of 
developing UC [8].
The reasons for these opposing effects of smoking on UC 
and CD have not been established; however, there are recent 
data linking the effect of tobacco smoking with genetics [9]. 
Helbig et al. found that smoking may modulate the functional 
consequences of the CD-associated polymorphism in NOD2 
[10]. Another proposed mechanism of action is associated 
with a difference in CD and UC immune response (secretion 
of pro-inflammatory cytokine associated with Th-1 versus 
Th-2, respectively), differences in microbiome composition, 
gut permeability and mucosal barrier function [11, 12, 13]. 
The effects of smoking on the intestinal microbiome have 
been demonstrated in several studies. There is also growing 
evidence that smoking may alter non-intestinal microbiome 
and decrease its diversity. These findings may explain the 
potential role of smoking in the pathogenesis of extra-
intestinal IBD symptoms [14].
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Smoking is a major issue because almost one-third of the 
adult population in Europe smokes, and only approximately 
10% of them start smoking after 20 years of age. [15] In 
Poland, 20.6% of adolescents were found to be active smokers 
[16]. Data on smoking in patients with IBD are limited and are 
based on adult data only. These data indicate that awareness of 
the negative impact of smoking is inadequate among patients 
with IBD. There is no evidence that smoking has deleterious 
effects on adolescents with CD; however, it is very probable. 
Regardless, adolescents with CD become adults with CD, 
and then this effect is proven. In contrast, adolescents, as 
opposed to adults, are more likely to smoke for a short period 
of time and not (yet) in a habitual manner. Therefore, it 
can be said that quitting smoking, while not easy in all age 
groups, is relatively easier in adolescents than in adults. It 
would be worthwhile to prepare programmes of smoking 
awareness early enough for children and adolescents with 
IBD to prevent smoking for non-smokers, and encourage 
quitting for smokers. Such a programme would also be 
worthwhile for adolescents with UC, because they can believe 
that smoking is beneficial for them, forgetting that cigarette 
smoking harms nearly every organ of the body, causes many 
diseases, including pulmonary and cardiovascular diseases, 
as well as various types of cancers, and affects the general 
health of smokers [17].
OBJECTIVES
We do not know what adolescents with IBD know about 
smoking and about the impact of smoking on their disease. 
For these reasons, this study aimed to evaluate the knowledge 
of adolescent patients with IBD regarding the effects of 
smoking on IBD.
MATERIALS AND METHOD
This prospective, controlled study was conducted in two 
university-affiliated hospitals for children in Warsaw and 
Kraków, Poland, between April 2016 – June 2017.
The study group was comprised of children and adolescents 
older than 11 years of age, and diagnosed with IBD at least 
one year before inclusion into the study. The diagnosis of 
CD or UC was based on clinical signs and symptoms, as 
well as on endoscopic, histological and radiological results, 
according to the revised Porto criteria [18]. The patients were 
at different stages of the disease and treatment process. The 
control group consisted of healthy children of the same age. 
All study participants were asked to fill in an anonymous 
one-page questionnaire which consisted of 20 questions. In 
the first part, three general questions were asked regarding 
age, gender and type of respondent: healthy control or patient 
suffering from IBD (with CD or UC). Next two questions 
were addressed only to the latter group and regarded disease 
duration and current status of the illness: remission or 
disease flare.
The study participants were then asked about their smoking 
behavior: current, former, never or passive smoker. They were 
also asked if they are occasional or everyday smokers. In 
the second part of the questionnaire, all study participants 
were asked their opinion about a list of the potential effects 
of smoking on health issues, including general health, risk 
of heart infarct, stroke, influenza, lung cancer, and asthma. 
Additionally, children and adolescents with IBD were asked 
if smoking increases the risk for developing IBD, extra-
intestinal symptoms of IBD and the IBD course, and surgery. 
Answers included “yes”, “no” and “do not know” options.
Continuous variables were expressed as medians (IQRs 
– interquartile rates) based on the data distribution. The 
Mann-Whitney U test was used to compare median values 
between groups. The χ2 or Fisher’s exact test was used to 
compare proportions. The Yates correction for continuity was 
used when appropriate. Odds ratio (OR) and 95% confidence 
interval (CI) were calculated. Data analysis was conducted 
using Statistica 12 (Statsoft, Oklahoma, USA).
The study protocol was approved by the Ethics Committee 
on Research at the Medical University in Warsaw. All patients 
were informed about the study objectives.
RESULTS
In total, 139 patients with IBD and 108 controls were enrolled 
in the study. None of the patients refused to participate, 
and all of them correctly completed the survey. The clinical 
characteristics of patients and controls are shown in Table 1. 
At the time of enrollment, there were no differences in age, 
gender, disease duration and disease activity between patients 
with CD and UC. There was also no difference in smoking 







N 139 84 55 108
Age in years (median, IQR) 15 (14–17) 15 (14–17) 15 (14–17) 0.99 15 (14–17) 0.96
Gender (males) 77 (55.4%) 46 (54.8%) 31 (56.4%) 0.3 49 (45.4%) 0.1
Disease duration (median years, IQR) 2 (1–6) 2 (1–6) 2 (1–5) 0.9
Patients in remission 69 (49.6%) 46 (54.8%) 23 (41.8%) 0.1
Active smokers 17 (12.2%) 7 (8.3%) 10 (18.2%) 0.08 18 (16.7%) 0.3




Every day smokers 11 (64.7%) 4 (57.1%) 7 (70%) 3 (16.7%)
Quit smoking Attempts 4 (23.5%) 2 (28.6%) 2 (20%) 1.0 13 (72.2%) 0.005
Passive smokers 45 (32.4%) 30 (35.7%) 15 (27.3) 0.3 35 (32.4%) 1.0
IBD – inflammatory bowel disease; CD – Crohn’s disease; UC – ulcerative colitis, IQR interquartile rate
62 Annals of Agricultural and Environmental Medicine 2020, Vol 27, No 1
Marcin Dziekiewicz, Kinga Kowalska-Duplaga, Marta Baranowska-Nowak, Magdalena Neścioruk, Stefan Kuźniarski, Marcin Banasiuk. Awareness of smoking…
behaviour between patients with CD and UC. However, there 
were more occasional smokers and attempts to quit smoking 
in the control group than in the IBD group (p=0.004 and 
p=0.005, respectively). Patients with IBD were nine times 
more likely to be everyday smokers than occasional smokers 
(OR=9.2, 95% CI: 1.9 – 45.1; p=0.004). Taking patients with 
IBD and controls together, smokers were older compared to 
non-smokers (median age 17 years (IQR: 16–17) vs. 15 years 
(IQR: 14–16; p=0.000) and were twice as likely to be males 
(OR=2.6, 95% CI: 1.1 – 5.1; p=0.03).
Figure 1 shows the results of replies to questions directed 
to all study participants. There were no differences in answers 
to questions about the impact of smoking on health issues, 
including general health, risk of myocardial infarction, 
influenza, lung cancer or asthma, among patients with CD, 
patients with UC and controls. More controls determined 
smoking as a risk factor for stroke, compared to patients 
with IBD (93.7% vs. 79.2%, respectively; p=0.02); there was 
no difference between CD and UC patients (p=0.9).
In the questions below, for the statistical assessment, we 
excluded only “do not know” answers. Patients’ knowledge 
regarding the effects of smoking on IBD is presented in 
Figure 2. No differences were found between CD and UC 
patients in correct answers to questions regarding whether 
smoking increases the risk for developing CD: 17/49 (34.7%) 
vs. 8/24 (33.3%), respectively (p=0.09). Both CD and UC 
patients were aware that smoking decreases the risk for 
developing UC: 32/46 (69.6%) vs. 21/28 (75%), respectively 
(p=0.6).
No differences were also between CD and UC patients 
in answers to the question whether “smoking increases the 
risk for surgery in your type of IBD” (17/28 (60.7%) vs. 10/29 
(34.5%), respectively (p=0.47).
To the questions: “Do you think that smoking increases the 
risk for extra-intestinal symptoms in your type of IBD?” and 
“Do you think that smoking may cause a more severe course 
of your type of IBD?”, patients with CD were 11 times and 
19 times more likely to give the correct answers, compared to 
patients with UC: OR=11.29 (95%CI: 4.12 – 30.89; p=0.000) 
and OR=19.33 (95% CI: 6.71 – 55.09; p=0.000), respectively.
There were no differences between smokers and non-
smokers regarding responses to all questions, with one 
exception: non-smokers more frequently gave the correct 
answer to question about the impact of smoking on asthma 
(97% vs. 82.1%; p=0.005). 73.3% of passive smokers, but none 
of active smokers, knew that smoking increases the risk of 
extra-intestinal manifestation (p = 0.01).
DISCUSSION
The results of this prospective trial demonstrate that 
knowledge regarding the deleterious effects of smoking 
on general health is good among adolescents with IBD; 
however, it is strongly insufficient with regard to the impact 
of smoking on their disease. To-date, a few studies assessing 
the awareness of smoking in adult patients with IBD have 
already been published [19, 20, 21, 22].
In this study, more than 95% of adolescents with IBD, 
both CD and UC, knew that smoking affects general health 
and asthma control, and increases the risk of myocardial 
infarction and lung cancer. Fewer IBD adolescents (although 
still almost 80%) knew that smoking increases the risk of 
stroke. Less than half of the respondents (41.1%) were aware 
of the fact that smoking increases the risk of influenza. The 
obtained results are in line with the results of studies in 
Figure 1. Patient’s awareness about smoking as a risk factor for general health issues (expressed as % of “yes” answers).
CD – Crohn’s disease; UC – ulcerative colitis; C – control
Figure 2. Patient’s beliefs about the effect of smoking on inflammatory bowel 
disease (expressed as % of correct answers: “yes” for patients with CD and “no” 
for patients with UC).
CD – Crohn’s disease; UC – ulcerative colitis; IBD – inflammatory bowel disease
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adults with IBD; between 89% – 98% of adult patients 
thought that smoking increases the risk of lung cancer and 
cardiovascular disease [20,22]. Moreover, in the only adult 
study that involved questions about smoking and influenza, 
the results were very similar to those in the current study 
(32% of adult IBD patients vs. 41.7% in the current study) [20].
Similar to this study, there was also no difference between 
the answers of IBD patients and those of controls. The only 
significant difference found in the results of this part of the 
questionnaire was the fact that more controls found smoking 
to be a risk factor for stroke, compared to patients with IBD; 
however, the rate was high in both groups and there was no 
difference between CD and UC patients. de Bie et al. found a 
very similar association: 87% of controls recognized smoking 
as a risk factor for stroke, compared to 81% of patients with 
CD [20]. Patients with IBD, similar to the general population, 
were strongly aware of the adverse effects of smoking on 
general health [23]. In the presented study, approximately 
one-third of patients with IBD gave correct answers to the 
question of whether smoking increases the risk of developing 
CD. Twice as many patients believed that smoking does not 
influence the onset of UC. The results of studies conducted 
in adults are differential. Between 9.5% [22] and 64.3% [21] 
of patients with IBD gave the correct answers regarding this 
issue. In the studies in which patients with CD were aware of 
the role of smoking in promoting the development of their 
disease, patients with UC were not aware of this [19, 20, 24]. 
When patients with CD were not aware of the influence 
of smoking on the onset of their disease, the majority of 
patients with UC knew about the preventive role of smoking 
in the development of UC [21]. The rates of awareness about 
smoking effect on the onset of IBD is still unsatisfactory. In 
the opinion of the authors of the current study, it is much 
more difficult to explain to patients with UC that they should 
not smoke, although tobacco use my have a protective effect 
on their disease.
This study shows that many more adolescents with CD 
knew that smoking affects their disease than did their peers 
with UC. Similar findings were reported by Ducharme-
Benard et al. in their Canadian cohorts of adults with IBD 
[19]. In contrast, only a minority of British and French 
patients with CD recognized that smoking increases the risk 
of additional operations for their disease [21, 22]. The most 
plausible explanation is the different level of knowledge about 
smoking between adolescents with CD and UC. However, 
the authors of the current study concede that they suspect 
that the proper answers given by adolescents with IBD are 
not the result of higher disease-related knowledge, but rather 
the common opinion that “smoking is bad” and is therefore 
also “bad for CD and bad for UC”. However, the authors 
have no proof for their suspicion. Moreover, although the 
study group comprised of more frequent UC smokers than 
CD smokers, no differences were found in knowledge of the 
impact of smoking on the course of IBD between smokers 
and non-smokers. This finding indicates that knowledge 
about smoking as an exacerbating factor of IBD concerns 
patients with both types of the disease equally.
In this study, 12% of patients declared that they were current 
smokers. It is believed that these data are accurate because the 
questionnaire was anonymous, and parents were requested 
to allow their children to complete the questionnaire in 
isolation. Similar rates of smoking (16%) were also found in 
controls. This finding indicates that smoking is less popular 
in adolescents than in adults. Saadoune et al. reported that 
in their groups of patients with IBD, 31% were smokers 
[21], and Ryan et al. reported that 32% were smokers [22]. 
In Poland in 2014,almost one-third of the population were 
to be active smokers, and the majority of them started to 
smoke in adolescence and young adulthood [25]. Attempts 
to quit smoking were statistically more frequent in the 
control group than in the IBD group. This be a result of the 
fact that there were many more occasional smokers in the 
control group than in the patients’ group. A lower number of 
cigarettes smoked per day is a known predictor of smoking 
cessation [26].
The results of this study emphasize the need for health 
professionals to organize systematic education for patients 
with IBD regarding the risk of smoking associated with their 
disease. Moreover, smoking cessation programmes should 
be routinely incorporated into the management of IBD from 
the time of IBD diagnosis.
The main advantage of this study is the fact that, for the 
first time, knowledge of the adverse effects of smoking on IBD 
among a group of adolescents with IBD has been assessed. 
The study groups were representative because all patients and 
controls, and their parents who were invited to participate 
in the study, agreed to do so.
However, the study also has shortcomings. The study 
participants were not asked about the sources of their 
knowledge on smoking. Therefore, it was not possible to 
determine whether doctors or nurses gave any support to 
adolescents’ decisions to smoke or not. Also, were not asked 
if their decision to quit smoking was associated with the 
advice of doctors or nurses. Moreover, it was not possible to 
explain why attempts to quit smoking were more frequent 
in the control group than in the IBD group (p=0.005). 
Unfortunately, on the basis of this study, the role of the 
medical staff in the participants’ knowledge about the 
harmful effects of smoking could not be assessed.
In conclusion, the data obtained demonstrate that 
adolescents with CD and UC are aware of the harmful effects 
of smoking on general health, influenza, asthma, myocardial 
infarction and lung cancer. Adolescents with CD are much 
more aware of the role of smoking on CD, compared to their 
peers with UC; however, this awareness is still unsatisfactory. 
There is an unmet need to implement routine educational 
strategies for this group of patients.
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